“…Baicalein, an aglycone of baicalin, is also widely studied in neuroinflammation. Baicalein inhibits microglia activation and polarization with decreasing TNF-α, iNOS, IL-1β, IL-6, CD16 and CD86 production, and enhancing Arg-1 and CD206 levels in LPS plus IFN-γ-induced BV2 cells through activating STAT1 expression and inhibiting TLR4/NF-κB pathway ( 38 ), and in ischemic penumbra from middle cerebral artery occlusion (MCAO)-induced rats through the inactivation of IκBα, JNK, ERK and p38, as well as nuclear translocation of p65 ( 38 – 40 ). In other studies, baicalein is reported to reduce IFN-γ, IL-5, and IL-12 secretion, as well as repress GFAP and Iba-1 expression in substantia nigra (SN) and midbrain from MPTP or rotenone-induced PD mice via downregulating cleaved-Caspase-1, cleaved-GSDMD, and NLRP3, as well as promoting PSD95, SYP, BDNF, p-TrkB, CREB, p-PI3k, p-Akt, and p-CaMK II expression ( 41 , 42 ).…”